Nov 11, 2021 / 02:40PM GMT
Rebecca Kotkin -
Hi, good morning, everyone. This is Rebecca Kotkin with Credit Suisse's Healthcare Equity Capital Markets. I'm pleased to be joined today by Paul Lévesque from Theratechnologies, who will commence into a presentation shortly thereafter. As a reminder to those that are joining via the web, you can ask questions via e-mail. My e-mail addresses is rebecca.kotkin@credit-suisse. I'd be happy to moderate those questions after Paul's prepared remarks. And with that, let me hand it over to Paul Lévesque, CEO and President of Theratechnologies.
Paul Lévesque - Theratechnologies Inc. - President, CEO & Director
Thank you very much, Rebecca, and welcome, everyone, for joining today. It's always exciting to have a chance to review who we are. So I'm going to try to have an update on certain things for people today, but also an overview so that people who do not know Theratechnologies and the exciting programs that we have, yet they have a good understanding of who we are and where we come from, but certainly, where we are heading to. So
Theratechnologies Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot